Semaglutide Mechanism of Action Semaglutide, sold under the brand name Ozempic and Wegovy among others, is an anti-diabetic medication used for the treatment of type 2 diabetes and chronic weight management
What you will learn in this article: Retatrutide is an investigational triple G agonisttargeting GLP-1, GIP, and glucagon receptorscurrently in Phase 3 clinical trials by Eli Lilly
Effect of insulin-regulated FOXC2 expression in adipocyte differentiation and insulin resistance
This narrative review summarizes the current clinical evidence on GLP-1RAs in PsO and PsA and discusses future research directions aimed at evaluating their potential role in intercepting PsA development and improving outcomes in patients with complex immunometabolic profiles
NNMT inhibition with 5-Amino-1MQ reduced white adipose tissue mass by ~35% in diet-induced obese mouse models without suppressing food intake, suggesting energy expenditure modulation
These arise because GLP1 agonists slow stomach emptying and intensify satiety signals, which can leave you feeling uncomfortably full after small meals and trigger food aversions